ADiTx Therapeutics, Inc. (ADTX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Amro Albanna
Employees:
60
11161 ANDERSON STREET, SUITE 105-10014, LOMA LINDA, CA 92354
909-488-0844

Aditxt, Inc. develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies.

Data derived from most recent annual or quarterly report
Market Cap 3.913 Million Shares Outstanding4.296 Million Avg 30-day Volume 37.777 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-5.27
Price to Revenue16.5342 Debt to Equity0.1727 EBITDA-39.175 Million
Price to Book Value1.1112 Operating Margin-4837.7953 Enterprise Value7.054 Million
Current Ratio2.887 EPS Growth0.609 Quick Ratio2.4
1 Yr BETA 0.458 52-week High/Low 28.49 / 0.83 Profit Margin-5100.9892
Operating Cash Flow Growth-45.6003 Altman Z-Score-11.5633 Free Cash Flow to Firm -24.264 Million
View SEC Filings from ADTX instead.

View recent insider trading info

Funds Holding ADTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ADTX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2023-03-21:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-13:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2023-02-24:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-20:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-06:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-23:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-20:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-02:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-14:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-03:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • Proposed Sales (Form 144)

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    ALBANNA AMRO A. CHIEF EXECUTIVE OFFICER

    • Officer
    1 2022-07-19 1

    SHATZKES MATTHEW CHIEF LEGAL OFFICER AND GC

    • Officer
    0 2022-01-28 0

    ANTHONY LAURA E

    • Director
    11,500 2021-09-29 0

    RUNGE JEFFREY W.

    • Director
    11,500 2021-09-29 0

    BRADY BRIAN MICHAEL

    • Director
    11,500 2021-09-29 0

    KIAIE NAMVAR

    • Director
    11,500 2021-09-29 0

    SHABAHANG SHAHROKH CHIEF INNOVATION OFFICER

    • Officer
    105,000 2021-07-22 0

    ALBANNA ROWENA CHIEF OPERATING OFFICER

    • Officer
    100,000 2021-07-22 0

    FARLEY THOMAS J CHIEF FINANCIAL OFFICER

    • Officer
    155,000 2021-07-22 0

    CHUNG LAUREN

    • Director
    28,000 2021-07-14 0

    PANKOVCIN CORINNE CHIEF FINANCIAL OFFICER

    • Officer
    169,220 2021-06-04 0

    MCLEOD ROSLAND FISHER

    • Director
    0 2020-07-10 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ADITXT INC ADTX 2023-03-31 22:15:04 UTC -86.6547 91.4747 25000
    ADITXT INC ADTX 2023-03-31 21:45:05 UTC -86.6547 91.4747 25000
    ADITXT INC ADTX 2023-03-31 21:15:03 UTC -86.6547 91.4747 25000
    ADITXT INC ADTX 2023-03-31 20:45:04 UTC -86.6547 91.4747 25000
    ADITXT INC ADTX 2023-03-31 20:15:04 UTC -86.6547 91.4747 25000
    ADITXT INC ADTX 2023-03-31 19:45:04 UTC -86.6547 91.4747 25000
    ADITXT INC ADTX 2023-03-31 19:15:04 UTC -86.6547 91.4747 25000
    ADITXT INC ADTX 2023-03-31 18:45:04 UTC -86.6547 91.4747 25000
    ADITXT INC ADTX 2023-03-31 18:15:04 UTC -86.6547 91.4747 25000
    ADITXT INC ADTX 2023-03-31 17:45:04 UTC -86.6547 91.4747 25000
    ADITXT INC ADTX 2023-03-31 17:15:03 UTC -86.6547 91.4747 25000
    ADITXT INC ADTX 2023-03-31 16:45:04 UTC -82.631 87.451 25000
    ADITXT INC ADTX 2023-03-31 16:15:04 UTC -82.631 87.451 25000
    ADITXT INC ADTX 2023-03-31 15:45:04 UTC -82.631 87.451 25000
    ADITXT INC ADTX 2023-03-31 15:15:03 UTC -82.631 87.451 20000
    ADITXT INC ADTX 2023-03-31 14:45:04 UTC -82.631 87.451 20000
    ADITXT INC ADTX 2023-03-31 14:15:04 UTC -82.631 87.451 20000
    ADITXT INC ADTX 2023-03-31 13:45:03 UTC -90.3006 95.1206 20000
    ADITXT INC ADTX 2023-03-31 13:15:03 UTC -90.3006 95.1206 8000
    ADITXT INC ADTX 2023-03-31 12:45:03 UTC -90.3006 95.1206 10000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund ADTX -20.0 shares, $-23.4 2022-12-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments